With Analysis of 20 Genomes, Duke Team Demonstrates Proof of Concept for Sequencing Disease Cohorts

Sep 21, 2010

Premium

Researchers at Duke's Genomic Analysis Facility have sequenced and characterized the genomes of 20 individuals: 10 with hemophilia A that were also exposed to HIV, and 10 without hemophilia and not exposed to HIV.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Alan Rabson Dies

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

ECRI Institute to Offer Medical Guidelines

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

This Week in Genome Research

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

Places to Talk About It

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.

Featured White Papers

Reliable Collection of High-Quality Samples for Gut Microbiome Studies

Can Saliva Replace Blood for DNA Collection and Analysis?

The Ultimate Guide to Mouse Clinical Trials

Sep

17

Featured Webinar

Trends in Clinical NGS QC Management: Expert Insights to Ensure Quality Results for Your Lab

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Main menu